Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqihuoxuejiedu Formula is a Traditional Chinese Medicine (TCM) herbal composition developed by Guang'anmen Hospital of the China Academy of Chinese Medical Sciences. It is utilized as a tailored immunotherapy for the treatment of advanced ovarian cancer. The formula is designed to tonify Qi, promote blood circulation, and detoxify, which in TCM theory helps to counteract tumor progression. Mechanistically, it has been shown to modulate the immune system by regulating the levels and activity of Regulatory T cells (Tregs) within the tumor microenvironment. Clinical research has focused on how inherited single nucleotide polymorphisms (SNPs) may influence the formula's immunomodulatory effects, supporting a personalized medicine approach in integrative oncology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yiqihuoxuejiedu Formula.